3-POINT IMPROVEMENT IN IGA HAND AND FOOT SCORE

Actual adult patient treated with DUPIXENT. Not a clinical trial patient. Scoring was designated by the healthcare professional. Because this was a real-world patient, other factors, including concomitant therapies, may have influenced treatment results. Individual results may vary.

BASELINE:
IGA 4 (severe) WEEK 16:
IGA 2 (mild)

BASELINE:
IGA 4 (severe) WEEK 16:
IGA 2 (mild)

A clinical responder was defined as a patient achieving IGA hand and foot 0 or 1.¹